1 / 14

Module 7: Malaria and HIV/AIDS

Palliative Care for People Living with HIV/AIDS. Module 7: Malaria and HIV/AIDS. Learning Objectives. Describe the interactions between malaria and HIV. Discuss strategies for preventing malaria as part of the palliative care package.

vernon
Download Presentation

Module 7: Malaria and HIV/AIDS

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Palliative Care for People Living with HIV/AIDS Module 7:Malaria and HIV/AIDS

  2. Learning Objectives • Describe the interactions between malaria and HIV. • Discuss strategies for preventing malaria as part of the palliative care package. • Implement strategies to treat malaria among people with HIV/AIDS. Module 7: Malaria and HIV/AIDS

  3. Background • Malaria and HIV/AIDS are both endemic in Ethiopia: • 50 million people are at risk for malaria. • 9 million reported cases annually. • Leading cause of morbidity and mortality. • 0.9–3.5% HIV prevalence, 420,000, 1.3 million with HIV/AIDS • The most vulnerable groups for malaria and HIV/AIDS are similar: pregnant women, young children, the poor. • Coordinated service delivery can help prevention and treatment of both diseases. Module 7: Malaria and HIV/AIDS Source: UNICEF; FMOH, 2004; FMOH, 2006; UNAIDS, 2007

  4. Impact of HIV/AIDS on Malaria • People with HIV/AIDS are more likely to have symptomatic malaria, severe malaria, and anemia. • Prevalence and density of placental and peripheral parasitemia are higher in HIV-infected pregnant women. • Pregnant women coinfected with HIV and malaria are at higher risk for anemia, preterm birth, and low birth weight infants. • Antimalarial treatment failure may be more common in people with low CD4 counts. Sources: Francesconi, et al, 2001; French, et al, 2001; Patnak, et al, 2005; ter Kuile, et al, 2004; Ayisi, et al, 2003 Module 7: Malaria and HIV/AIDS

  5. Impact of Malaria on HIV/AIDS • Long-term data are lacking • Acute malarial episodes cause a temporary increase in viral replication • Placental malaria may increase viral load Module 7: Malaria and HIV/AIDS Sources: Kublin, et al, 2005; Whitworth, et al, 2005

  6. Module 7: Malaria and HIV/AIDS

  7. Malaria Control and Prevention Strategies in Ethiopia • Rapid diagnosis and prompt treatment. • Selective vector control: • ITN (Insecticide treated nets). • IRS (indoor residual spray). • Others: • Environmental modification. • Larviciding. • Early detection and containment of malaria epidemic. • Other strategies that work are intermittent presumptive treatment of pregnant women, pCTX, HAART. • Focus on children <5 years and pregnant women in endemic areas. Module 7: Malaria and HIV/AIDS

  8. Uganda Study • Combination of: • pCTX • ART • Treated nets • Associated with a 95% reduction in the incidence of symptomatic malaria among people with HIV/AIDS. Module 7: Malaria and HIV/AIDS Source: Mermin, et al, 2006

  9. Insecticide-Treated Nets (ITNs) • In Africa, ITNs have been shown to reduce all cause mortality by 20%. • ITNs will have a public health impact if >80% of the population at risk uses them. • Pregnant women and children under five living in malarial areas are the top priority for ITN. • Application of insecticide (dipping) greatly enhances the protective efficacy of bed nets. • Long lasting nets are distributed in Ethiopia, which is advantageous because they don’t need pretreatment. Module 7: Malaria and HIV/AIDS

  10. Malaria Treatment (1) • Use laboratory tests to diagnose malaria when possible. The Ethiopian guidelines recommend: • Health post level: clinical or clinical + RDT • Health center and hospital level: Microscopy • Use laboratory tests in HIV-positive people whenever possible • HIV/malaria coinfected patients may show different clinical symptoms. • Look for and treat anemia. Module 7: Malaria and HIV/AIDS

  11. Malaria Treatment (2) • Rapid treatment with artemisinin-based combination therapy (ACT). • Contraindicated in children <5 kg and pregnant women. Module 7: Malaria and HIV/AIDS

  12. Unanswered Questions • What is the impact of malaria on MTCT? • What are some interactions between antimalarial drugs and ARVs? • What is the relationship between pCTX and malaria? • Note: Preventive therapy for pregnant women on pCTX not advised by WHO. • What is the role of pCTX in preventing peripheral and placental malaria? Module 7: Malaria and HIV/AIDS

  13. Key Points • Integration of malaria and HIV prevention and treatment activities is crucial. • People with HIV/AIDS are more likely to have symptomatic and severe malaria, and anemia. • Pregnant women and children with HIV/AIDS are most at risk for malaria. • Education on preventive measures and provision of ITNs is part of the HIV care package. • The use of ITNs, pCTX, and ART can greatly reduce malaria incidence in people with HIV. • Watch for interactions of ACT and ARVs. Module 7: Malaria and HIV/AIDS

  14. Module 7 Wrap-Up Module 7: Malaria and HIV/AIDS

More Related